APO RESEARCH · REPORT
Cell Banking Outsourcing
A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.
Product & engineering
Understand the product.
A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.
Selected research
Industry Research
Cell Banking Outsourcing Industry Research Report 2026
Market perspective
A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.
North America is the largest Cell Banking Outsourcing market with about 38% market share. Europe is follower, accounting for about 22% market share.The key manufacturers are SGS Life Sciences, Lonza, CCBC, Vcanbio, AMAG Pharmaceuticals, ViaCord, Thermo Fisher, Wuxi Apptec, CordLife, Esperite, Reliance Life Sciences, Lifecell, Cryo-Cell, Toxikon, Goodwin Biotechnology, Texcell, Cryo Stemcell etc. Top 3 companies occupied about 13% market share.
Report Scope
Read the full market overview
This report quantifies the global Cell Banking Outsourcing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell Banking Outsourcing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell Banking Outsourcing Market by Company
SGS Life Sciences
Lonza
CCBC
Vcanbio
AMAG Pharmaceuticals
ViaCord
Thermo Fisher
Wuxi Apptec
CordLife
Esperite
Reliance Life Sciences
Lifecell
Cryo-Cell
Toxikon
Goodwin Biotechnology
Texcell
Cryo Stemcell
Cell Banking Outsourcing Segment by Type
Stem Cell Banking
Non-stem Cell Banking
Cell Banking Outsourcing Segment by Application
Cell Bank Storage
Bank Characterization and Testing
Cell Bank Preparation
Cell Banking Outsourcing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Banking Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Banking Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Banking Outsourcing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell Banking Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cell Banking
- Non-stem Cell Banking
Applications
- Cell Bank Storage
- Bank Characterization and Testing
- Cell Bank Preparation
Companies covered
- SGS Life Sciences
- Lonza
- CCBC
- Vcanbio
- AMAG Pharmaceuticals
- ViaCord
- Thermo Fisher
- Wuxi Apptec
- CordLife
- Esperite
- Reliance Life Sciences
- Lifecell
- Cryo-Cell
- Toxikon
- Goodwin Biotechnology
- Texcell
- Cryo Stemcell
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell Banking Outsourcing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Stem Cell Banking
- 2.2.3 Non-stem Cell Banking
- 2.3 Cell Banking Outsourcing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cell Bank Storage
- 2.3.3 Bank Characterization and Testing
- 2.3.4 Cell Bank Preparation
- 2.4 Assumptions and Limitations
3 Cell Banking Outsourcing Breakdown Data by Type
- 3.1 Global Cell Banking Outsourcing Historic Market Size by Type (2021-2026)
- 3.2 Global Cell Banking Outsourcing Forecasted Market Size by Type (2027-2032)
4 Cell Banking Outsourcing Breakdown Data by Application
- 4.1 Global Cell Banking Outsourcing Historic Market Size by Application (2021-2026)
- 4.2 Global Cell Banking Outsourcing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell Banking Outsourcing Market Perspective (2021-2032)
- 5.2 Global Cell Banking Outsourcing Growth Trends by Region
- 5.2.1 Global Cell Banking Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell Banking Outsourcing Historic Market Size by Region (2021-2026)
- 5.2.3 Cell Banking Outsourcing Forecasted Market Size by Region (2027-2032)
- 5.3 Cell Banking Outsourcing Market Dynamics
- 5.3.1 Cell Banking Outsourcing Industry Trends
- 5.3.2 Cell Banking Outsourcing Market Drivers
- 5.3.3 Cell Banking Outsourcing Market Challenges
- 5.3.4 Cell Banking Outsourcing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell Banking Outsourcing Players by Revenue
- 6.1.1 Global Top Cell Banking Outsourcing Players by Revenue (2021-2026)
- 6.1.2 Global Cell Banking Outsourcing Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell Banking Outsourcing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell Banking Outsourcing Head Office and Area Served
- 6.4 Global Cell Banking Outsourcing Players, Product Type & Application
- 6.5 Global Cell Banking Outsourcing Manufacturers Established Date
- 6.6 Global Cell Banking Outsourcing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell Banking Outsourcing Market Size (2021-2032)
- 7.2 North America Cell Banking Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell Banking Outsourcing Market Size by Country (2021-2026)
- 7.4 North America Cell Banking Outsourcing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell Banking Outsourcing Market Size (2021-2032)
- 8.2 Europe Cell Banking Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell Banking Outsourcing Market Size by Country (2021-2026)
- 8.4 Europe Cell Banking Outsourcing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Banking Outsourcing Market Size (2021-2032)
- 9.2 Asia-Pacific Cell Banking Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell Banking Outsourcing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell Banking Outsourcing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell Banking Outsourcing Market Size (2021-2032)
- 10.2 South America Cell Banking Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell Banking Outsourcing Market Size by Country (2021-2026)
- 10.4 South America Cell Banking Outsourcing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Banking Outsourcing Market Size (2021-2032)
- 11.2 Middle East & Africa Cell Banking Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell Banking Outsourcing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell Banking Outsourcing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 SGS Life Sciences
- 12.1.1 SGS Life Sciences Company Information
- 12.1.2 SGS Life Sciences Business Overview
- 12.1.3 SGS Life Sciences Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.1.4 SGS Life Sciences Cell Banking Outsourcing Product Portfolio
- 12.1.5 SGS Life Sciences Recent Developments
- 12.2 Lonza
- 12.2.1 Lonza Company Information
- 12.2.2 Lonza Business Overview
- 12.2.3 Lonza Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.2.4 Lonza Cell Banking Outsourcing Product Portfolio
- 12.2.5 Lonza Recent Developments
- 12.3 CCBC
- 12.3.1 CCBC Company Information
- 12.3.2 CCBC Business Overview
- 12.3.3 CCBC Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.3.4 CCBC Cell Banking Outsourcing Product Portfolio
- 12.3.5 CCBC Recent Developments
- 12.4 Vcanbio
- 12.4.1 Vcanbio Company Information
- 12.4.2 Vcanbio Business Overview
- 12.4.3 Vcanbio Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.4.4 Vcanbio Cell Banking Outsourcing Product Portfolio
- 12.4.5 Vcanbio Recent Developments
- 12.5 AMAG Pharmaceuticals
- 12.5.1 AMAG Pharmaceuticals Company Information
- 12.5.2 AMAG Pharmaceuticals Business Overview
- 12.5.3 AMAG Pharmaceuticals Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.5.4 AMAG Pharmaceuticals Cell Banking Outsourcing Product Portfolio
- 12.5.5 AMAG Pharmaceuticals Recent Developments
- 12.6 ViaCord
- 12.6.1 ViaCord Company Information
- 12.6.2 ViaCord Business Overview
- 12.6.3 ViaCord Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.6.4 ViaCord Cell Banking Outsourcing Product Portfolio
- 12.6.5 ViaCord Recent Developments
- 12.7 Thermo Fisher
- 12.7.1 Thermo Fisher Company Information
- 12.7.2 Thermo Fisher Business Overview
- 12.7.3 Thermo Fisher Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.7.4 Thermo Fisher Cell Banking Outsourcing Product Portfolio
- 12.7.5 Thermo Fisher Recent Developments
- 12.8 Wuxi Apptec
- 12.8.1 Wuxi Apptec Company Information
- 12.8.2 Wuxi Apptec Business Overview
- 12.8.3 Wuxi Apptec Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.8.4 Wuxi Apptec Cell Banking Outsourcing Product Portfolio
- 12.8.5 Wuxi Apptec Recent Developments
- 12.9 CordLife
- 12.9.1 CordLife Company Information
- 12.9.2 CordLife Business Overview
- 12.9.3 CordLife Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.9.4 CordLife Cell Banking Outsourcing Product Portfolio
- 12.9.5 CordLife Recent Developments
- 12.10 Esperite
- 12.10.1 Esperite Company Information
- 12.10.2 Esperite Business Overview
- 12.10.3 Esperite Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.10.4 Esperite Cell Banking Outsourcing Product Portfolio
- 12.10.5 Esperite Recent Developments
- 12.11 Reliance Life Sciences
- 12.11.1 Reliance Life Sciences Company Information
- 12.11.2 Reliance Life Sciences Business Overview
- 12.11.3 Reliance Life Sciences Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.11.4 Reliance Life Sciences Cell Banking Outsourcing Product Portfolio
- 12.11.5 Reliance Life Sciences Recent Developments
- 12.12 Lifecell
- 12.12.1 Lifecell Company Information
- 12.12.2 Lifecell Business Overview
- 12.12.3 Lifecell Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.12.4 Lifecell Cell Banking Outsourcing Product Portfolio
- 12.12.5 Lifecell Recent Developments
- 12.13 Cryo-Cell
- 12.13.1 Cryo-Cell Company Information
- 12.13.2 Cryo-Cell Business Overview
- 12.13.3 Cryo-Cell Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.13.4 Cryo-Cell Cell Banking Outsourcing Product Portfolio
- 12.13.5 Cryo-Cell Recent Developments
- 12.14 Toxikon
- 12.14.1 Toxikon Company Information
- 12.14.2 Toxikon Business Overview
- 12.14.3 Toxikon Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.14.4 Toxikon Cell Banking Outsourcing Product Portfolio
- 12.14.5 Toxikon Recent Developments
- 12.15 Goodwin Biotechnology
- 12.15.1 Goodwin Biotechnology Company Information
- 12.15.2 Goodwin Biotechnology Business Overview
- 12.15.3 Goodwin Biotechnology Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.15.4 Goodwin Biotechnology Cell Banking Outsourcing Product Portfolio
- 12.15.5 Goodwin Biotechnology Recent Developments
- 12.16 Texcell
- 12.16.1 Texcell Company Information
- 12.16.2 Texcell Business Overview
- 12.16.3 Texcell Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.16.4 Texcell Cell Banking Outsourcing Product Portfolio
- 12.16.5 Texcell Recent Developments
- 12.17 Cryo Stemcell
- 12.17.1 Cryo Stemcell Company Information
- 12.17.2 Cryo Stemcell Business Overview
- 12.17.3 Cryo Stemcell Revenue in Cell Banking Outsourcing Business (2021-2026)
- 12.17.4 Cryo Stemcell Cell Banking Outsourcing Product Portfolio
- 12.17.5 Cryo Stemcell Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst